France-Israel: 4P-Pharma, SATT Aquitaine and Bordeaux University to develop an anti-cancer drug. Video
4P-Pharma has signed an exclusive license agreement with Aquitaine Science Transfert, for…
4P-Pharma has signed an exclusive license agreement with Aquitaine Science Transfert, for…
Bank Hapoalim CEO Arik Pinto and Peretz Lavie, president of the Technion…
Hydrogen photo-production in green algae, catalyzed by the enzyme [FeFe]-hydrogenase (HydA), is…
Rapid Medical, a company focused on the development of neurovascular interventional devices,…
IBM Alpha Zone accelerator offers a 20 week professional and deep immersion…
An international team announced today that a planet with a mass similar to…
Scientists at Technion have proposed an innovative system for harvesting safe drinking…
Researchers at Ben-Gurion University of the Negev (BGU) have determined that a…